Core Scientific, Inc.
CORZ · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $81 | $79 | $80 | $95 |
| % Growth | 3.1% | -1.1% | -16.2% | – |
| Cost of Goods Sold | $77 | $74 | $71 | $90 |
| Gross Profit | $4 | $5 | $8 | $5 |
| % Margin | 4.7% | 6.4% | 10.3% | 5% |
| R&D Expenses | $0 | $0 | $0 | $5 |
| G&A Expenses | $0 | $0 | $40 | $36 |
| SG&A Expenses | $69 | $57 | $40 | $39 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $3 |
| Other Operating Expenses | $0 | -$26 | $11 | $1 |
| Operating Expenses | $69 | $31 | $51 | $45 |
| Operating Income | -$65 | -$26 | -$43 | -$40 |
| % Margin | -80.7% | -33.4% | -53.6% | -41.9% |
| Other Income/Exp. Net | -$81 | -$910 | $623 | -$225 |
| Pre-Tax Income | -$147 | -$937 | $581 | -$265 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$147 | -$937 | $581 | -$266 |
| % Margin | -180.8% | -1,191.4% | 730.2% | -279.7% |
| EPS | -0.46 | -0.042 | 1.44 | -0.6 |
| % Growth | -1,003.1% | -102.9% | 340% | – |
| EPS Diluted | -0.46 | -0.042 | 1.25 | -0.6 |
| Weighted Avg Shares Out | 319 | 318 | 315 | 306 |
| Weighted Avg Shares Out Dil | 319 | 318 | 363 | 306 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $1 | $2 | $0 |
| Interest Expense | $0 | $0 | $0 | $1 |
| Depreciation & Amortization | $19 | $21 | $22 | $29 |
| EBITDA | -$127 | -$1 | -$20 | -$235 |
| % Margin | -157.2% | -0.8% | -25.4% | -247.4% |